How Often Should You Take Mounjaro, and Why the Schedule Matters

Why once a week? What the trial data tells us about the interval

The SURMOUNT-1 trial, which randomised 2,539 adults with obesity to tirzepatide or placebo over 72 weeks, used a fixed once-weekly injection schedule throughout, it was not an arbitrary choice. Tirzepatide's molecular design gives it a plasma half-life of roughly five days, meaning a weekly injection maintains consistent receptor engagement at the GIP and GLP-1 sites without the peaks and troughs a shorter interval would create. In that trial, participants on the 15 mg dose achieved average body-weight reductions of around 20–21%, a result published in the New England Journal of Medicine. The schedule that generated those results is the same licensed schedule used in UK clinical practice today: one injection per week, titrated upward by the prescriber. There is no evidence that injecting more frequently produces better outcomes; it would produce more side effects and is outside the licensed use of the medicine, though researchers are separately exploring what microdosing Mounjaro for inflammation might offer in contexts beyond standard weight management.

Picking a consistent day matters more than which day you pick. If Sunday works because you're not rushing, use Sunday. The body doesn't care about the calendar, it cares about the interval staying close to seven days.

What the titration schedule actually looks like, dose by dose

The licensed UK titration path begins at 2.5 mg. That first pen is not a treatment dose in the therapeutic sense; its job is to introduce tirzepatide to your system gradually, reducing the likelihood of nausea or vomiting during the adjustment period. After four weeks at 2.5 mg, the prescriber typically moves to 5 mg, then 7.5 mg, and so on, with roughly four weeks at each level. The six available strengths (2.5, 5, 7.5, 10, 12.5 and 15 mg) give prescribers flexibility to slow the titration if side effects are troublesome or to hold at a dose that is working well.

Not everyone needs to reach 15 mg. Some people find 7.5 or 10 mg produces good results with fewer gastrointestinal side effects; a prescriber's role is to find the right dose for you, not to escalate mechanically to the maximum. If you're weighing up whether Mounjaro is right for your situation at all, our page on whether Mounjaro is right for you covers the broader eligibility picture.

Staying safe between injections: what to watch and when to act

Common side effects (nausea, loose stools, constipation, indigestion, fatigue) tend to be most noticeable in the days immediately after an injection, particularly after a dose increase, and usually settle as your body adjusts over days to a couple of weeks. A practical habit worth building: the evening before your injection day, check your pen in the fridge. Confirm the liquid is clear and colourless, the expiry date is valid, and the pen is undamaged. That thirty-second check each week is far easier than discovering a problem on injection morning.

More serious symptoms require prompt attention regardless of where you are in the weekly cycle. Severe abdominal pain that radiates to the back (with or without vomiting) needs urgent medical assessment because acute pancreatitis, though infrequent, is a recognised risk with GLP-1 medicines. The MHRA highlighted this in a January 2026 Drug Safety Update. Signs of a serious allergic reaction, gallbladder pain, or significant dehydration from persistent vomiting or diarrhoea also warrant the same urgency. You can report suspected side effects at any time through the MHRA Yellow Card scheme. For anything urgent, contact your prescriber, call NHS 111, or go to A&E.

Questions about medicines that interact with the weekly schedule (for instance, how metoclopramide might affect your treatment) are worth raising directly with your prescriber before combining anything. Our overview of metoclopramide and Mounjaro covers the key considerations.

What happens if your dosing day shifts, or you miss an injection?

Life moves the needle sometimes. If you realise you've missed an injection, the appropriate response depends on how many days have passed. The exact guidance on timing windows lives in the Patient Information Leaflet that comes with your pen, and your prescriber is the right person to confirm what to do in your specific situation. As a general rule, the answer is never to take a double dose, that much is consistent across all clinical guidance for once-weekly injectables.

If you're tracking your progress week to week alongside the dosing schedule, our page on how often to weigh yourself on Mounjaro has practical guidance on interpreting the numbers without letting them drive anxiety. And if you're curious how tirzepatide compares to weekly semaglutide in terms of the dosing experience, the tirzepatide overview lays out both mechanisms clearly.

For a broader look at what private weight-loss treatment actually costs (and what a legitimate price includes) the Mounjaro price comparison page breaks that down honestly. Starting point for anyone considering treatment is always a clinical consultation, where a prescriber reviews your full picture before anything is prescribed.